↓ Skip to main content

Outcomes of multiple myeloma patients receiving bortezomib, lenalidomide, and carfilzomib

Overview of attention for article published in Annals of Hematology, December 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news
1 news outlet
twitter
6 X users

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
27 Mendeley